Niu M, Li X, Li M, Chen F, Cao H, Liu Q
Inflammopharmacology. 2025; .
PMID: 40063187
DOI: 10.1007/s10787-025-01708-y.
Sun Y, Wang M, Ling J, Wu Q, Han G, Zhou J
Hum Cell. 2024; 38(1):35.
PMID: 39718697
DOI: 10.1007/s13577-024-01164-w.
Feng T, Zhou Y, Mao X, Rui X, Cai L
Integr Cancer Ther. 2024; 23:15347354241294043.
PMID: 39511708
PMC: 11544674.
DOI: 10.1177/15347354241294043.
Gu X, Zhou H, Miao M, Hu D, Wang X, Zhou J
Drug Des Devel Ther. 2024; 18:3667-3696.
PMID: 39188919
PMC: 11345706.
DOI: 10.2147/DDDT.S464910.
Zhang P, Liu H, Yu Y, Peng S, Zhu S
Front Pharmacol. 2024; 15:1430284.
PMID: 39170702
PMC: 11336575.
DOI: 10.3389/fphar.2024.1430284.
Curcumol ameliorates neuroinflammation after cerebral ischemia-reperfusion injury via affecting microglial polarization and Treg/Th17 balance through Nrf2/HO-1 and NF-κB signaling.
Liu Y, Wang W, Di B, Miao J
Cell Death Discov. 2024; 10(1):300.
PMID: 38914581
PMC: 11196256.
DOI: 10.1038/s41420-024-02067-3.
Research Progress on Sesquiterpenoids of and Their Pharmacological Effects.
Cui T, Li B, Liu F, Xiong L
Biomolecules. 2024; 14(4).
PMID: 38672405
PMC: 11048675.
DOI: 10.3390/biom14040387.
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective.
Fu Y, Wang Z, Qin H
Metabolites. 2024; 14(4).
PMID: 38668346
PMC: 11052500.
DOI: 10.3390/metabo14040218.
Icariin‑curcumol promotes ferroptosis in prostate cancer cells through Nrf2/HO‑1 signaling.
Sheng W, Li B, Sun T, Zhu C, Li Y, Xu W
Exp Ther Med. 2024; 27(5):232.
PMID: 38628654
PMC: 11019657.
DOI: 10.3892/etm.2024.12519.
Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure-activity relationships, and potential applications.
Zhai S, Wang R, Wang J, Xu X, Niu L, Guo M
Inflammopharmacology. 2024; 32(3):1659-1704.
PMID: 38520574
DOI: 10.1007/s10787-024-01447-6.
Curcumol metabolized by rat liver S9 fraction and orally administered in mouse suppressed the proliferation of colon cancer in vitro and in vivo.
Zhou Y, Moon J, Kim J, Qiu S, Lee S, Park H
Food Sci Biotechnol. 2024; 33(1):171-180.
PMID: 38186621
PMC: 10767046.
DOI: 10.1007/s10068-023-01321-1.
Characterization and Evaluation of Silk Sericin-Based Hydrogel: A Promising Biomaterial for Efficient Healing of Acute Wounds.
Munir F, Tahir H, Ali S, Ali A, Tehreem A, Zaidi S
ACS Omega. 2023; 8(35):32090-32098.
PMID: 37692226
PMC: 10483651.
DOI: 10.1021/acsomega.3c04178.
Comprehensive chemical profiling of two Dendrobium species and identification of anti-hepatoma active constituents from Dendrobium chrysotoxum by network pharmacology.
Jie X, Feng Y, Jiahao F, Ganggui L, Jiani Y, Zhongyu X
BMC Complement Med Ther. 2023; 23(1):217.
PMID: 37393306
PMC: 10314590.
DOI: 10.1186/s12906-023-04048-y.
Curcumol β-cyclodextrin inclusion complex enhances radiosensitivity of esophageal cancer under hypoxic and normoxic condition.
Su M, Ren X, Du D, He H, Zhang D, Xie R
Jpn J Radiol. 2023; 41(11):1275-1289.
PMID: 37227584
PMC: 10613597.
DOI: 10.1007/s11604-023-01446-7.
Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review.
Li Y, Li H, He Q, Yang X
Molecules. 2023; 28(1).
PMID: 36615387
PMC: 9822070.
DOI: 10.3390/molecules28010195.
Discovering the potential active ingredients of Qi-Yu-San-Long decoction for anti-oxidation, inhibition of non-small cell lung cancer based on the spectrum-effect relationship combined with chemometric methods.
Huang M, Li R, Yang M, Zhou A, Wu H, Li Z
Front Pharmacol. 2022; 13:989139.
PMID: 36339563
PMC: 9627220.
DOI: 10.3389/fphar.2022.989139.
Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis.
Sheng W, Ding J, Liu L, Wang N, Lu B, You X
Evid Based Complement Alternat Med. 2022; 2022:9317402.
PMID: 35942374
PMC: 9356804.
DOI: 10.1155/2022/9317402.
Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.
Wang J, Jin J, Chen T, Zhou Q
Molecules. 2022; 27(14).
PMID: 35889217
PMC: 9318016.
DOI: 10.3390/molecules27144345.
Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking LC3B-Lamin B1 Interaction in Alcoholic Fatty Liver Disease.
Qi X, Zheng S, Ma M, Lian N, Wang H, Chen L
Front Pharmacol. 2022; 13:912825.
PMID: 35837283
PMC: 9273900.
DOI: 10.3389/fphar.2022.912825.
Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin.
Mao Z, Zhong L, Zhuang X, Liu H, Peng Y
Evid Based Complement Alternat Med. 2022; 2022:3988916.
PMID: 35795276
PMC: 9251105.
DOI: 10.1155/2022/3988916.